BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Leukocyte
,
Hematopoietic cell
,
Rosiglitazone
,
rs7903146
,
IL1A
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PP2A‐ C
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic kidney cells with MAP4K4 shRNA knockdown
Mammary glands with normal involution from WAP-T1 SV40 transgenic and wildtype mice
Mammary carcinomas from SV40 transgenic mice with different grades of disease
Bronchial epithelial cells with TP53 shRNA knockdown and PCDH7 overexpression
Gastric cancer HGC-27 cells with siRNA-mediated STRN3 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
The protein phosphatase Siw14 controls caffeine-induced nuclear localization and phosphorylation of …
PP2A-C may be a promising candidate for postmortem interval estimation.
c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-m…
PP2 protects from keratin mutation-associated liver injury and filament disruption via SRC kinase in…
PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Res…
Metformin and Nightly Fasting in Women With Early Breast Cancer
Duality of Lipids: the Athlete's Paradox
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Smal…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ